My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 99

    1.

    Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline.

    Schiffman M, Clifford G, Buonaguro FM.

    Infect Agent Cancer. 2009 Jun 1;4:8.PMID: 19486508 [PubMed]Free PMC ArticleFree textRelated citations

    2.

    Annual disease burden due to human papillomavirus 16 and 18 infections in Finland.

    Syrjänen KJ.

    Scand J Infect Dis Suppl. 2009;108:2-32.PMID: 19939209 [PubMed - indexed for MEDLINE]Related citations

    3.

    Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States.

    Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WG, Castle PE.

    J Natl Cancer Inst. 2009 Apr 1;101(7):475-87. Epub 2009 Mar 24.PMID: 19318628 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    4.

    Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial.

    Paavonen J, Jenkins D, Bosch FX, Naud P, Salmerón J, Wheeler CM, Chow SN, Apter DL, Kitchener HC, Castellsague X, de Carvalho NS, Skinner SR, Harper DM, Hedrick JA, Jaisamrarn U, Limson GA, Dionne M, Quint W, Spiessens B, Peeters P, Struyf F, Wieting SL, Lehtinen MO, Dubin G; HPV PATRICIA study group.

    Lancet. 2007 Jun 30;369(9580):2161-70. Erratum in: Lancet. 2007 Oct 20;370(9596):1414. PMID: 17602732 [PubMed - indexed for MEDLINE]Related citations

    5.

    The carcinogenicity of human papillomavirus types reflects viral evolution.

    Schiffman M, Herrero R, Desalle R, Hildesheim A, Wacholder S, Rodriguez AC, Bratti MC, Sherman ME, Morales J, Guillen D, Alfaro M, Hutchinson M, Wright TC, Solomon D, Chen Z, Schussler J, Castle PE, Burk RD.

    Virology. 2005 Jun 20;337(1):76-84.PMID: 15914222 [PubMed - indexed for MEDLINE]Related citations

    6.

    The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.

    Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M.

    J Natl Cancer Inst. 2005 Jul 20;97(14):1072-9.PMID: 16030305 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    7.

    Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality.

    Kovacic MB, Castle PE, Herrero R, Schiffman M, Sherman ME, Wacholder S, Rodriguez AC, Hutchinson ML, Bratti MC, Hildesheim A, Morales J, Alfaro M, Burk RD.

    Cancer Res. 2006 Oct 15;66(20):10112-9.PMID: 17047075 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    8.

    Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.

    Syrjänen KJ.

    Scand J Infect Dis Suppl. 2009;107:3-32. Review.PMID: 19408160 [PubMed - indexed for MEDLINE]Related citations

    9.

    Identification of HLA-DR1- and HLA-DR15-restricted human papillomavirus type 16 (HPV16) and HPV18 E6 epitopes recognized by CD4+ T cells from healthy young women.

    Gallagher KM, Man S.

    J Gen Virol. 2007 May;88(Pt 5):1470-8.PMID: 17412975 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    10.

    Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.

    Arbyn M, Benoy I, Simoens C, Bogers J, Beutels P, Depuydt C.

    Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):321-30.PMID: 19124515 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    11.

    The IARC commitment to cancer prevention: the example of papillomavirus and cervical cancer.

    Franceschi S.

    Recent Results Cancer Res. 2005;166:277-97. Review.PMID: 15648196 [PubMed - indexed for MEDLINE]Related citations

    12.

    Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

    Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP).

    MMWR Recomm Rep. 2007 Mar 23;56(RR-2):1-24.PMID: 17380109 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    13.

    Human papillomavirus infection and the primary and secondary prevention of cervical cancer.

    Lowy DR, Solomon D, Hildesheim A, Schiller JT, Schiffman M.

    Cancer. 2008 Oct 1;113(7 Suppl):1980-93. Review.PMID: 18798536 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    14.

    Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.

    Arbyn M, Dillner J.

    J Clin Virol. 2007 Mar;38(3):189-97. Epub 2007 Jan 25. Review.PMID: 17258503 [PubMed - indexed for MEDLINE]Related citations

    15.

    A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia.

    Schiffman M, Rodriguez AC, Chen Z, Wacholder S, Herrero R, Hildesheim A, Desalle R, Befano B, Yu K, Safaeian M, Sherman ME, Morales J, Guillen D, Alfaro M, Hutchinson M, Solomon D, Castle PE, Burk RD.

    Cancer Res. 2010 Apr 15;70(8):3159-69. Epub 2010 Mar 30.PMID: 20354192 [PubMed - indexed for MEDLINE]Related citations

    16.

    Development of an HPV vaccine for a broad spectrum of high-risk types.

    Kanda T, Kondo K.

    Hum Vaccin. 2009 Jan-Feb;5(1):43-5. Epub 2009 Jan 7.PMID: 18690012 [PubMed - indexed for MEDLINE]Related citations

    17.

    [Evaluation of carcinogenic risk at the international (International Agency for Research on Cancer--World Health Organization) and the Czechoslovak level. A basis for consideration prior to amending Guideline no. 64/1984 on hygienic principles in working with chemical carcinogens]

    Srb V.

    Cas Lek Cesk. 1989 Aug 18;128(34):1057-64. Czech. PMID: 2790913 [PubMed - indexed for MEDLINE]Related citations

    18.

    Indications and efficacy of the human papillomavirus vaccine.

    Hakim AA, Lin PS, Wilczynski S, Nguyen K, Lynes B, Wakabayashi MT.

    Curr Treat Options Oncol. 2007 Dec;8(6):393-401. Review.PMID: 18172770 [PubMed - indexed for MEDLINE]Related citations

    19.

    Age-appropriate use of human papillomavirus vaccines in the U.S.

    Castle PE, Fetterman B, Akhtar I, Husain M, Gold MA, Guido R, Glass AG, Kinney W.

    Gynecol Oncol. 2009 Aug;114(2):365-9. Epub 2009 May 22. Review.PMID: 19464729 [PubMed - indexed for MEDLINE]Related citations

    20.

    Comparison of the SPF10-LiPA system to the Hybrid Capture 2 Assay for detection of carcinogenic human papillomavirus genotypes among 5,683 young women in Guanacaste, Costa Rica.

    Safaeian M, Herrero R, Hildesheim A, Quint W, Freer E, Van Doorn LJ, Porras C, Silva S, González P, Bratti MC, Rodriguez AC, Castle P; Costa Rican Vaccine Trial Group.

    J Clin Microbiol. 2007 May;45(5):1447-54. Epub 2007 Mar 7.PMID: 17344361 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...
    You are here: NCBI > Literature > PubMed
    Write to the Help Desk